- Home
- GDO vs NVRO Comparison
GDO vs NVRO Comparison
Compare GDO & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDO
- NVRO
- Stock Information
- Founded
- GDO 2009
- NVRO 2006
- Country
- GDO United States
- NVRO United States
- Employees
- GDO N/A
- NVRO N/A
- Industry
- GDO Finance Companies
- NVRO Medical/Dental Instruments
- Sector
- GDO Finance
- NVRO Health Care
- Exchange
- GDO Nasdaq
- NVRO Nasdaq
- Market Cap
- GDO 169.4M
- NVRO 139.0M
- IPO Year
- GDO N/A
- NVRO 2014
- Fundamental
- Price
- GDO $11.27
- NVRO $4.57
- Analyst Decision
- GDO
- NVRO Hold
- Analyst Count
- GDO 0
- NVRO 14
- Target Price
- GDO N/A
- NVRO $7.97
- AVG Volume (30 Days)
- GDO 39.4K
- NVRO 572.2K
- Earning Date
- GDO 01-01-0001
- NVRO 02-19-2025
- Dividend Yield
- GDO 9.81%
- NVRO N/A
- EPS Growth
- GDO N/A
- NVRO N/A
- EPS
- GDO N/A
- NVRO N/A
- Revenue
- GDO N/A
- NVRO $419,146,000.00
- Revenue This Year
- GDO N/A
- NVRO N/A
- Revenue Next Year
- GDO N/A
- NVRO $0.64
- P/E Ratio
- GDO N/A
- NVRO N/A
- Revenue Growth
- GDO N/A
- NVRO N/A
- 52 Week Low
- GDO $11.21
- NVRO $3.17
- 52 Week High
- GDO $13.04
- NVRO $19.47
- Technical
- Relative Strength Index (RSI)
- GDO 48.59
- NVRO 60.51
- Support Level
- GDO $10.92
- NVRO $3.17
- Resistance Level
- GDO $11.25
- NVRO $3.99
- Average True Range (ATR)
- GDO 0.12
- NVRO 0.33
- MACD
- GDO 0.03
- NVRO 0.13
- Stochastic Oscillator
- GDO 85.37
- NVRO 93.98
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.